Jane C.

Regulatory & Safety Strategist I Clinical Pharmacist

United States

About

Experience

  • AbbVie (6 yrs 9 mos)
    • Associate Director - Global Regulatory Strategy, US/Canada Lead
      May 2022 - Sep 2025 · 3 yrs 5 mos

      Developed and executed US and Canada regulatory strategy for multiple neuroscience products in varying clinical trial phases and indications.

    • Associate Director, Safety Data Sciences
      Jun 2021 - May 2022 · 1 yr

      Prepared and presented comprehensive summaries of safety issues for neurology and immunology products to multi-disciplinary Product Safety Teams

    • Asian Leadership Network Social Alliances Co-Chair
      Jul 2020 - Aug 2021 · 1 yr 2 mos

      Collaborate with other Employee Resource Groups (ERGs) to highlight social issues. Coordinate events that promote equity, diversity, and inclusion within AbbVie.

  • Clinical Staff Pharmacist at UChicago Medicine
    Sep 2018 - Jan 2019 · 5 mos

  • Research Student and Manuscript Author at Midwestern University (IL)
    Mar 2016 - Jul 2018 · 2 yrs 5 mos

    Assisted with the development of an elective course that emphasized increasing cultural health awareness at health screenings in minority communities. Assisted with teaching the students as well as writing the manuscript for publication.

  • PGY-1 Pharmacy Resident at Loma Linda University Health
    Jul 2017 - Jun 2018 · 1 yr

    Longitudinal: Teaching Certificate Research Project Inpatient Staffing Experiences Learning experiences: 1. Pharmacy Administration 2. Cardiac and General Transplant 3. Internal Medicine 4. Coronary/Cardiac Care Unit (CCU) 5. Surgical ICU 6. Infectious Diseases 7. Emergency Medicine

  • Loma Linda University (Loma Linda, CA)
    • Clinical Research and Manuscript Author
      Jun 2017 - Jun 2018 · 1 yr 1 mo

      Designed and implemented a clinical research project that observed the use of Rifaximin in reducing endotoxins in septic shock patients at a level 1 trauma, academic medical center. Submitted the IRB, collected data, and helped write the manuscript for publication. Presentations: 1. Lee JY, Abraham N, Koch LeGrand S, Kinney J. Rifaximin in the treatment of septic patients. Poster presented at the 52nd Annual ASHP Midyear Clinical Meeting and Exhibition; Orlando, FL. Dec 3-7, 2017. 2. Rifaximin for the Reduction of Endotoxins in Septic Shock presented at the Western States Conference in San Diego, CA. May 2018.

    • Pharmacy Practice Instructor
      Jan 2018 - Mar 2018 · 3 mos

      Created activities for learning (i.e. cases for in-class assignments, simulation lab exercises for patient counseling, evaluation of orders). Taught and graded activities for a group of 24 Loma Linda University School of Pharmacy third-year student pharmacists.